학술논문
Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)
Document Type
Academic Journal
Author
Rosenthal, E; Fougerou‐Leurent, C; Renault, A; Carrieri, MP; Marcellin, F; Garraffo, R; Teicher, E; Aumaitre, H; Lacombe, K; Bailly, F; Billaud, E; Chevaliez, S; Dominguez, S; Valantin, MA; Reynes, J; Naqvi, A; Cotte, L; Metivier, S; Leroy, V; Dupon, M; Allegre, T; De Truchis, P; Jeantils, V; Chas, J; Salmon‐Ceron, D; Morlat, P; Neau, D; Perré, P; Piroth, L; Pol, S; Bourlière, M; Pageaux, GP; Alric, L; Zucman, D; Girard, PM; Poizot‐Martin, I; Yazdanpanah, Y; Raffi, F; Pabic, E Le; Tual, C; Pailhé, A; Amri, I; Bellissant, E; Molina, JM; Gérard, Laurence; Duvivier, Claudine; Lafeuillade, Alain; Batisse, Dominique; Mortier, Emmanuel; Simon, Anne; Makhloufi, Djamila; Michelet, Christian; Cheret, Antoine; May, Thierry; Moreau, Jacques; de Ledinghen, Victor; Rosa, Isabelle; Ahmim, Mustapha; Raimon, Julie; Thierry, Régine; Martin, Amélie
Source
HIV Medicine. Mar 01, 2018 19(3):227-237
Subject
Language
English
ISSN
1464-2662